Physician
Oncology
Dr. Samir E. Witta, MD
|
|
Give Review
Dr. Samir E. Witta practices Oncology. He over the years received 1 awards: "Regional Top Doctor". Samir Witta is a published doctor and has 18 publications published. The lastest was: 'Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats.' He is registered with Medicare.
Publications
- Histone deacetylase inhibitors in non-small-cell lung cancer.
- Supportive care.
- Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluoresce...
- ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).
- A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors.
- Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
- Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
- Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
- Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
- Characterization of the Bex gene family in humans, mice, and rats.
- Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
- Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer.
- A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors.
- Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats.
- Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortal...
- XIPOU 2 is a potential regulator of Spemann''s Organizer.
- XIPOU 2, a noggin-inducible gene, has direct neuralizing activity.
Schools
Charles University 1st Faculty Of Medicine
Nestn Pennsylvania Affil
University Of Colorado
National Institute Of Health
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Colorado -
Karlovy University Faculty of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1013991678 | |
| NPPES Provider LastName | WITTA | |
| NPPES Provider FirstName | SAMIR | |
| NPPES Provider ZIPCode | 804015027 | |
| NPPES Provider State | CO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 677.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 64.0 | |
| Percent Opioid Claims | 9.45 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013991678 |
| Last Name Of The Provider | WITTA |
| First Name Of The Provider | SAMIR |
| View All |
Similar Doctors
|
Dr. Robert S. Kantor, MD
 This Doctor is OpenDoctor Recommended.
|